Enhancement of Bioavailability of Clopidogrel Using Different Solubility Enhancement Techniques
Schlagwörter:
Clopidogrel, Solubility enhancement techniques, encapsulation complex, solvent deposition, surface solid dispersion.Abstract
Bioavailability is the key determinant of a drug for its therapeutic effectiveness, which in turn depends upon the solubility of that drug in gastro intestinal fluid. Clopidogrel is a BCS class II drug. Drugs of this category have low solubility and high permeability, so their bioavailability is less. This can be overcome by doing pharmaceutic modifications on it. In the present study, three different modifications, namely, complexation, solvent deposition and surface solid dispersion were utilized to improve the solubility. Preformulation studies included solubility, melting point determination and compatibility studies. FTIR, solubility analysis, in vitro drug release study and kinetic studies were done for all the formulations. Solubility study results showed better solubility of formulations. The mechanism of drug release from formulations was found to be super case 2 transport. From all these evaluations, the F3Sol.D was taken as better formulation. The F3Sol.D was subjected to further evaluation before formulating it into capsule form. The values of angle of repose and Carrs index show that the powder is having good flow properties. F3Sol.D was formulated into capsule. Capsules were evaluated for properties like content uniformity, weight uniformity and disintegration. In vitro dissolution studies showed 96% release at 60th min. Clopidogrel capsules were found to pass one month stability studies as per ICH guidelines. Keywords: Clopidogrel, solubility enhancement techniques, encapsulation complex, solvent deposition, surface solid dispersionCite this Article Arun Raj R, Nadiya KK, Jyoti Harindran. Enhancement of Bioavailability of Clopidogrel Using Different Solubility Enhancement Techniques. Research and Reviews: A Journal of Pharmaceutical Science. 2016; 7(2): 25–39p.
Veröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
